No Data
Huaxia Eye Hospital (301267.SZ): The company's proportion of Medicare income is not high.
On January 15, Gelonghui reported that Huaxia Eye Hospital (301267.SZ) indicated during an investor relations activity that the proportion of the company's medical insurance income is not high, and the settlement situation of the medical insurance Fund is similar to previous years, with no significant changes.
Huaxia Ophthalmology (301267.SZ): The surgical structure of the refractive Business will remain stable overall in 2024.
On January 15, Gelonghui reported that Huaxia Eye Hospital (301267.SZ) stated during an investor relations activity that in 2024, the structure of the refractive Business remained stable overall, with no significant changes in the proportions of various sub-surgical procedures.
Calculating The Intrinsic Value Of Huaxia Eye Hospital Group Co.,Ltd. (SZSE:301267)
Hua Xia Ophthalmology (301267.SZ): has repurchased a total of 0.89% of its shares.
On January 3rd, Gelonghui reported that Huaxia Eye Hospital (301267.SZ) announced that as of December 31, 2024, the company has repurchased a total of 7,452,540 shares through a special account for stock repurchase via centralized auction trading, accounting for 0.89% of the company's current total share capital, with a highest Fill Price of 30.93 yuan/share, a lowest Fill Price of 19.38 yuan/share, and a total transaction amount of 0.1996 billion yuan (excluding transaction fees).
Huaxia Eye (301267.SZ): Currently does not involve AI glasses related products
Grandall 29th November | Huaxia Ophthalmology (301267.SZ) stated on the investor interaction platform that the company's main business is ophthalmology medical services, and it has not yet been involved in AI glasses related products. The company continues to closely monitor the development of new technologies and products in the ophthalmology industry, actively seeking investment opportunities that align with the company's development global strategy and planning.
Huaxia Eye Hospital GroupLtd's (SZSE:301267) Soft Earnings Don't Show The Whole Picture
Returns On Capital At Huaxia Eye Hospital GroupLtd (SZSE:301267) Have Hit The Brakes
